Iain Simpson

This inventor holds 25 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Drug Discovery. Top assignees: Proximagen Limited, Astrazeneca Ab, Astrazeneca Ab (Publ). Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iain Simpson. Retrieved from https://idiyas.com/inventor/iain-simpson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 15)

% Patents Active = 40.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 55(Granted Patents)

Location History:

Cheshire, GB (2006)
Macclesfield, GB (2010)
London, GB (2015 - 2016)
Cambridge, GB (2012 - 2024)

Company Filing History:

Astrazeneca Ab (Publ)

patents

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Arginase Inhibitors

CXCR4 Antagonists

SSAO Inhibitors

Tricyclic Compounds

Pyridine Derivatives

Enzyme Inhibitors

Inflammatory Disease

Glycogen Phosphorylase

Immunomodulatory Compounds

Anticancer Agents

Weight Gain Treatment

Heterocyclic Amides

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435097 - Arginase inhibitors and methods of use thereof (2025-10-07),

2. 12410187 - Fused tricyclic compounds useful as anticancer agents (2025-09-09),

3. 12195485 - Arginase inhibitors and methods of use thereof (2025-01-14),

4. 11912727 - Arginase inhibitors and methods of use thereof (2024-02-27),

5. 11530208 - Imidazo[4,5-C]pyridine derived SSAO inhibitors (2022-12-20),

6. 11512082 - Substituted imidazo[4,5-c]pyridine compounds and compositions thereof (2022-11-29),

7. 11420984 - Arginase inhibitors and methods of use thereof (2022-08-23),

8. 10995091 - CXCR4 receptor antagonists (2021-05-04),

9. 10968223 - Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors (2021-04-06),

10. 10766897 - Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors (2020-09-08),

11. 10590125 - Compounds (2020-03-17),

12. 10428066 - Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors (2019-10-01),

13. 10155761 - CXCR4 receptor antagonists (2018-12-18),

14. 9951068 - Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors (2018-04-24),

15. 9676769 - Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors (2017-06-13),

Title: The Innovative Contributions of Iain Simpson in Cambridge

Introduction

Iain Simpson is a distinguished inventor based in Cambridge, GB, with a remarkable track record of 23 patents. His innovative work primarily focuses on pharmaceutical compositions and their applications in treating serious health conditions, making significant contributions to the field of biomedical research.

Latest Patents

Among his latest patents, Iain has developed arginase inhibitors and methods of use thereof. This invention discloses compounds of formula (Ia) or pharmaceutically acceptable salts, aimed at creating pharmaceutical compositions and methods for treating cancer and respiratory inflammatory diseases by inhibiting arginase. This breakthrough has the potential to change the treatment landscape for these critical health issues.

Career Highlights

Iain has had an impressive career, having worked with reputable companies such as Proximagen Limited and AstraZeneca AB. His experience in these organizations has allowed him to hone his skills and contribute to major advancements in pharmaceutical innovations.

Collaborations

Throughout his career, Iain has collaborated with talented professionals such as Edward Savory and Lee Patient. These collaborations have fostered an environment of creativity and driven research that has led to the development of valuable medical solutions.

Conclusion

Iain Simpson's contributions to the field of pharmaceuticals through his innovative patents exemplify the impact of dedicated inventors in advancing healthcare. His work continues to inspire others in the scientific community, paving the way for new treatments that address critical medical challenges.

Profile summary based on public USPTO records.